Relationship between mean platelet volume and central serous chorioretinopathy

被引:0
作者
Ayhan Dursun
Mustafa Ilker Toker
Ayşe Vural Ozec
Erman Bozali
Kadir Kirboga
Feyza Gulac Dursun
Haydar Erdogan
Aysen Topalkara
Mustafa Kemal Arici
机构
[1] Cumhuriyet University,Department of Ophthalmology, School of Medicine
[2] Bozok University,Department of Ophthalmology, School of Medicine
[3] Numune Hospital,Department of Ophthalmology
来源
International Ophthalmology | 2017年 / 37卷
关键词
Central serous chorioretinopathy; Mean platelet volume;
D O I
暂无
中图分类号
学科分类号
摘要
The aim of this study was to investigate the mean platelet volume (MPV) of patients with central serous chorioretinopathy (CSCR). Thirty patients were included in the study. Thirty healthy volunteers were recruited as the control group. All patients and control subjects underwent complete ocular examination. Hemoglobin, hematocrit, white blood cell, neutrophil, lymphocyte, platelet count, and MPV of the participants were recorded. Data of patients with CSCR were compared with the control subjects. Patients with CSCR had significantly higher MPV values (9.76 ± 1.36 fL) compared with the control subjects (8.37 ± 0.72 fL) (p = 0.004). No significant difference was found in platelet counts between the CSCR group and the control group (259 ± 53.75 and 243 ± 52.11 K/Ul, p = 0.253). According to the receiver operator characteristics curve analysis, the optimal cut-off value of MPV to predict the CSCR was >9.4, with 60.0 % sensitivity and 93.3 % specificity. Our results demonstrated that the MPV values were significantly higher in patients with CSCR. MPV may be used as a predictive tool for identifying risk for CSCR.
引用
收藏
页码:119 / 124
页数:5
相关论文
共 183 条
[1]  
Nicholson B(2013)Central serous chorioretinopathy: update on pathophysiology and treatment Surv Ophthalmol 58 103-126
[2]  
Noble J(2010)Low-dose aspirin as treatment for central serous chorioretinopathy Clin Ophthalmol 4 899-903
[3]  
Forooghian F(2008)Central serous chorioretinopathy Acta Ophthalmol 86 126-145
[4]  
Meyerle C(2014)Common variants in the complement factor H gene confer genetic susceptibility to central serous chorioretinopathy Ophthalmology 121 1067-1072
[5]  
Caccavale A(1999)Systemic findings associated with central serous chorioretinopathy Am J Ophthalmol 128 63-68
[6]  
Romanazzi F(2006)Sympathetic parasympathetic activity and reactivity in central serous chorioretinopathy: a case–control study Invest Ophthalmol Vis Sci 47 3474-3478
[7]  
Imparato M(2004)Central serous chorioretinopathy case–control study group. Risk factors for central serous chorioretinopathy: a case–control study Ophthalmology 111 244-249
[8]  
Negri A(2009)Serum cortisol and testosterone levels in idiopathic central serous chorioretinopathy Indian J Ophthalmol 57 419-422
[9]  
Morano A(1986)Type A behavior and central serous chorioretinopathy Trans Am Ophthalmol Soc 84 799-845
[10]  
Ferentini F(2004)An association between central serous chorioretinopathy and gastroesophageal reflux disease Am J Ophthalmol 137 1096-1100